{"meshTagsMajor":["Chromosome Deletion","Genes, p53"],"meshTags":["Aged, 80 and over","Chromosome Deletion","Chromosomes, Human, Pair 5","Female","Genes, p53","Genes, ras","Humans","Male","Middle Aged","Mutation","Myelodysplastic Syndromes","fms-Like Tyrosine Kinase 3"],"meshMinor":["Aged, 80 and over","Chromosomes, Human, Pair 5","Female","Genes, ras","Humans","Male","Middle Aged","Mutation","Myelodysplastic Syndromes","fms-Like Tyrosine Kinase 3"],"genes":["NRAS","FLT3","TP53","del(5q)","NRAS","TP53 genes","FLT3 gene","NRAS","FLT3","TP53 mutation"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"abstract":"Mutations of the NRAS and TP53 genes and internal tandem duplication (ITD) of the FLT3 gene are among the most frequently observed molecular abnormalities in the myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). We sought to determine the incidence of these abnormalities in patients with MDS and a 5q deletion. NRAS and FLT3 mutations are uncommon in MDS patients with a 5q deletion and TP53 mutation is associated with the more advanced MDS subtypes.","title":"NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).","pubmedId":"15257941"}